Clinical Trial Detail

NCT ID NCT03988205
Title Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications

acute myeloid leukemia

Therapies

CPX-351

Age Groups: adult senior

No variant requirements are available.